«Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites». Neuropsychopharmacology, vol. 33, 8, 7-2008, pàg. 1952–65. DOI: 10.1038/sj.npp.1301590. PMID: 17957217.
«The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans». Pain, vol. 108, 1–2, 3-2004, pàg. 148–53. DOI: 10.1016/j.pain.2003.12.017. PMID: 15109518.
«Methylprednisolone and Ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds». Acta Anaesthesiol Scand, vol. 51, 9, 10-2007, pàg. 1138–46. DOI: 10.1111/j.1399-6576.2007.01415.x. PMID: 17714578.
«Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary Hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.». Pain, vol. 72, 1–2, 8-1997, pàg. 99–106. DOI: 10.1016/S0304-3959(97)00006-7. PMID: 9272793.
«The clinical role of NMDA receptor antagonists for the treatment of postoperative pain». Best Pract Res Clin Anaesthesiol, vol. 21, 1, 3-2007, pàg. 85–98. DOI: 10.1016/j.bpa.2006.12.006. PMID: 17489221.
«Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic Hyperalgesia.». Eur J Pain, vol. 12, 1, 1-2008, pàg. 17–29. DOI: 10.1016/j.ejpain.2007.02.002. PMID: 17449306.
«Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models». Drugs in R&D, vol. 8, 1, 2007, pàg. 51–57. DOI: 10.2165/00126839-200708010-00005. PMID: 17249849.
«Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites». Neuropsychopharmacology, vol. 33, 8, 7-2008, pàg. 1952–65. DOI: 10.1038/sj.npp.1301590. PMID: 17957217.
«The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans». Pain, vol. 108, 1–2, 3-2004, pàg. 148–53. DOI: 10.1016/j.pain.2003.12.017. PMID: 15109518.
«Methylprednisolone and Ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds». Acta Anaesthesiol Scand, vol. 51, 9, 10-2007, pàg. 1138–46. DOI: 10.1111/j.1399-6576.2007.01415.x. PMID: 17714578.
«Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary Hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.». Pain, vol. 72, 1–2, 8-1997, pàg. 99–106. DOI: 10.1016/S0304-3959(97)00006-7. PMID: 9272793.
«The clinical role of NMDA receptor antagonists for the treatment of postoperative pain». Best Pract Res Clin Anaesthesiol, vol. 21, 1, 3-2007, pàg. 85–98. DOI: 10.1016/j.bpa.2006.12.006. PMID: 17489221.
«Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic Hyperalgesia.». Eur J Pain, vol. 12, 1, 1-2008, pàg. 17–29. DOI: 10.1016/j.ejpain.2007.02.002. PMID: 17449306.
«Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models». Drugs in R&D, vol. 8, 1, 2007, pàg. 51–57. DOI: 10.2165/00126839-200708010-00005. PMID: 17249849.